Chenghui Ren - Concepedia

Author

Chenghui Ren

Lanzhou University

Also Known As

C Ren, Cheng-Hui Ren, Chenghui Ren, Chenyu Ren, Chunhuan Ren

Publications

819

Citations

H-Index

Concepts

All Affiliations

Lanzhou University First Hospital of Lanzhou University The University of Texas MD Anderson Cancer Center Baylor College of Medicine

About

Chenghui Ren is an author at Lanzhou University specializing in medicine, oxidative stress, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	254
2	Biochemistry	3	3	146
3	Natural Sciences	2	2	99
4	Cell Biology	2	2	113
5	Health Sciences	1	1	47

Chenghui Ren

Publications

804

Citations

H-Index

Page 1

	Year	Citations
Structure-based classification predicts drug response in EGFR-mutant NSCLC Jacqulyne Robichaux, Xiuning Le, R.S.K. Vijayan, Nature	2021	416
Reduced lysyl oxidase messenger RNA levels in experimental and human prostate cancer. Chenghui Ren, Guang Yang, T L Timme, PubMed Molecular BiologyCancer BiologyTumor BiologyHuman Prostate CancerOxidative Stress	1998	83
Relationship between intestinal microbial dysbiosis and primary liver cancer Lei Zhang, Yong-Na Wu, Tuo Chen, Hepatobiliary & pancreatic diseases international DysbiosisHepatologyGut MicrobiologyGastroenterologyPathology	2019	78
RTVP-1, a Tumor Suppressor Inactivated by Methylation in Prostate Cancer Chengzhen Ren, Likun Li, Guang Yang, Cancer Research	2004	64
Glutathione Might Attenuate Cadmium-Induced Liver Oxidative Stress and Hepatic Stellate Cell Activation Longfei Ren, Kuo Qi, Lei Zhang, Biological Trace Element Research HepatologyBiochemistryLiver PhysiologyPhysiologyLipid Peroxidation	2019	47
Tumor characteristics associated with engraftment of patient‐derived non–small cell lung cancer xenografts in immunocompromised mice Yungchang Chen, Ran Zhang, Li Wang, Cancer	2019	47
Dual role of cadmium in rat liver: Inducing liver injury and inhibiting the progression of early liver cancer Honglong Zhang, Jun Yan, Ye Xie, Toxicology Letters Early Liver CancerHepatologyDual RoleLiver PhysiologyPathology	2021	30
KRT-232 and navitoclax enhance trametinib's anti-Cancer activity in non-small cell lung cancer patient-derived xenografts with KRAS mutations. Xiaoshan Zhang, Ran Zhang, Huiqin Chen, PubMed	2020	23
Cadmium causes hepatopathy by changing the status of DNA methylation in the metabolic pathway Chenghui Ren, Longfei Ren, Jun Yan, Toxicology Letters ChromatinHepatologyBiochemistryNatural SciencesLiver Physiology	2020	16

Page 1